SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-023250
Filing Date
2022-06-21
Accepted
2022-06-21 07:30:09
Documents
1
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3620
  Complete submission text file 0000899243-22-023250.txt   5123
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Issuer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOLECULAR TEMPLATES, INC. 93010 AMBERGLEN BLVD., SUITE 100 AUSTIN TX 78729
Business Address
McLennan Sean (Reporting) CIK: 0001869698 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32979 | Film No.: 221026047